GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » NovoCure Ltd (STU:038) » Definitions » Shiller PE Ratio

NovoCure (STU:038) Shiller PE Ratio : (As of Jun. 11, 2024)


View and export this data going back to 2017. Start your Free Trial

What is NovoCure Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


NovoCure Shiller PE Ratio Historical Data

The historical data trend for NovoCure's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NovoCure Shiller PE Ratio Chart

NovoCure Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

NovoCure Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of NovoCure's Shiller PE Ratio

For the Medical Devices subindustry, NovoCure's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NovoCure's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, NovoCure's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where NovoCure's Shiller PE Ratio falls into.



NovoCure Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

NovoCure's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, NovoCure's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.331/131.7762*131.7762
=-0.331

Current CPI (Mar. 2024) = 131.7762.

NovoCure Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 0.000 100.560 0.000
201409 -0.197 100.428 -0.258
201412 -0.258 99.070 -0.343
201503 -0.298 99.621 -0.394
201506 -0.316 100.684 -0.414
201509 -0.280 100.392 -0.368
201512 -0.361 99.792 -0.477
201603 -0.377 100.470 -0.494
201606 -0.427 101.688 -0.553
201609 -0.347 101.861 -0.449
201612 -0.246 101.863 -0.318
201703 -0.196 102.862 -0.251
201706 -0.214 103.349 -0.273
201709 -0.109 104.136 -0.138
201712 -0.101 104.011 -0.128
201803 -0.187 105.290 -0.234
201806 -0.146 106.317 -0.181
201809 -0.111 106.507 -0.137
201812 -0.149 105.998 -0.185
201903 -0.115 107.251 -0.141
201906 -0.009 108.070 -0.011
201909 0.018 108.329 0.022
201912 0.036 108.420 0.044
202003 0.036 108.902 0.044
202006 0.018 108.767 0.022
202009 0.076 109.815 0.091
202012 0.033 109.897 0.040
202103 -0.034 111.754 -0.040
202106 -0.116 114.631 -0.133
202109 -0.111 115.734 -0.126
202112 -0.221 117.630 -0.248
202203 -0.036 121.301 -0.039
202206 -0.218 125.017 -0.230
202209 -0.253 125.227 -0.266
202212 -0.340 125.222 -0.358
202303 -0.467 127.348 -0.483
202306 -0.498 128.729 -0.510
202309 -0.431 129.860 -0.437
202312 -0.413 129.419 -0.421
202403 -0.331 131.776 -0.331

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


NovoCure  (STU:038) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


NovoCure Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of NovoCure's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


NovoCure (STU:038) Business Description

Traded in Other Exchanges
Address
Grenville Street, No. 4 The Forum, Second Floor, St. Helier, JEY, JE2 4UF
NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Ovarian Cancer, Pancreatic Cancer, Non-Small Cell Lung Cancer, and Brain Metastasis. Products are comprised of two main components: electric field generator and arrays and related accessories. NovoCure derives its major revenues in the United States.

NovoCure (STU:038) Headlines

No Headlines